Bioactive Constituents from the Roots of
Eurycoma longifolia

Jingya Ruan, Zheng Li, Ying Zhang, Yue Chen, Mengyang Liu, Lifeng Han, Yi Zhang, and Tao Wang

Abstract

Four new phenolic components, eurylophenolosides A (1) and B (2), eurylolignanosides A (3) and B (4), along with twelve known compounds were isolated from the roots of Eurycoma longifolia Jack. The structure of these components was elucidated by using various spectral techniques and chemical reactions. Among the known isolates, syringaldehyde (12), 3-chloro-4-hydroxybenzoic acid (13), 3-chloro-4-hydroxyl benzoic acid-4-O-ß-d-glucopyranoside (14), and isotachioside (15) were isolated from the Eurycoma genus for the first time. Further, the NMR data of 14 was reported here firstly. Meanwhile, the nitric oxide (NO) inhibitory activities of all compounds were examined in lipopolysaccharide (LPS)-stimulated RAW264.7 cells at 40 µM. As results, piscidinol A (6), 24-epi-piscidinol A (7), bourjotinolone A (10), and scopoletin (16) were found to play important role in suppressing NO levels without cytotoxicity. Furthermore, the Western blot method was used to investigate the mechanism of compounds 6, 7, 10, and 16 by analysing the level of inflammation related proteins, such as inducible nitric oxide synthase (iNOS), interleukin-6 (IL-6), and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-?B) in LPS-stimulated RAW264.7 cells. Consequently, compounds 6, 7, 10, and 16 were found to significantly inhibit LPS-induced protein expression of IL-6, NF-?B and iNOS in NF-?B signaling pathway. Moreover, it was found that the protein expression inhibitory effects of 6, 7, and 16 exhibited in a dose-dependent manner. The mechanism may be related to the inhibition of the iNOS expressions through suppressing the IL-6-induced NF-?B pathway.

References:

Hamzah, S. & Yusof, A. (2003), The ergogenic effects of Eurycoma longifolia Jack: a pilot study, British Journal of Sports Medicine, Volume 37: 464-470.

Liu, Ying; Lai, Lantao; Ju, Yan; Liu, Caihong; Meng, Dali (2019), Chemical constituents and synergistic anti-gout studies on Eurycoma longifolia and potential mechanisms evaluation based on systemic analysis approach, Bioorganic Chemistry, Volume 92

Nhan NH, Loc NH. (2017), Production of eurycomanone from cell suspension culture of Eurycoma longifolia , Pharmaceutical Biology Vol 55(1) Pages 2234-2239

Park, S., Nhiem, N. X., Kiem, P. V., Minh, C. V., Tai, B. H. et al. (2014), Five new quassinoids and cytotoxic constituents from the roots of Eurycoma longifolia, Bioorganic & Medicinal Chemistry Letters, Volume 24, Pages 3835-40.

Tong KL, Chan KL, AbuBakar S, Low BS, Ma HQ, Wong PF. (2015), The in vitro and in vivo anti-cancer activities of a standardized quassinoids composition from Eurycoma longifolia on LNCaP human prostate cancer cells, PLoS One. Vol 10(3)

Woodhouse, L. J., Gupta, N., Bhasin, M., Singh, A. B., Ross, R. et al. (2004), Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men, Journal of Clinical Endocrinology & Metabolism, Volume 89, Pages 718-26.

Zakaria, Y., Rahmat, A., Pihie, A. H., Abdullah, N. R. & Houghton, P. J. (2009), Eurycomanone induce apoptosis in HepG2 cells via up-regulation of p53, Cancer Cell International, Volume 9, Pages 16.

Tongkat Ali, Indonesian Root and Bark

40 Capsules @ 450 mg
https://www.amazon.com.au/dp/B09LT1JBY4
Product details

60 Capsules @ 450 mg
https://www.amazon.ca/dp/B09LXGMD2Q
Product details

65 Capsules @ 450 mg
https://www.amazon.ca/dp/B09LZ21397
Product details

70 Capsules @ 450 mg
https://www.amazon.com.au/dp/B099N4ML5R
Product details

120 Capsules @ 450 mg
https://www.amazon.com.au/dp/B09LT4R3CQ
Product details